Metabolomics is unique among omics technologies as it provides a complete functional readout of biological systems, revealing critical biomarkers that enhance the understanding of drug mechanisms and responses to therapy.

Dr. Karl Bradshaw, Chief Business Officer at Metabolon, highlighted that the combination of metagenomics and metabolomics provides deeper insights into the microbiome than either approach could achieve independently.

This integrated approach links microbial functions to host physiology and disease progression, offering deeper insights into microbiome activity compared to traditional methods.

The solution includes user-friendly bioinformatics tools designed for researchers of all levels, featuring gold-standard pipelines for processing sequencing data and machine learning capabilities to analyze complex data.

These bioinformatics tools are essential for analyzing microbial community composition and identifying key microbial groups, making complex data analysis accessible to both expert and novice researchers.

While metagenomics focuses on identifying microbial species and their genetic potential, metabolomics measures small molecules to capture the metabolic activities of these microbes.

This innovative solution allows customers to select from various sequencing methods and depths, aligning metagenomics data with metabolomic and phenotypic information.

The integration of machine learning within the tools helps uncover relationships between microbial community composition and metabolic profiles, facilitating the identification of biomarkers associated with specific phenotypes.

Metabolon, Inc. has unveiled a new microbiome research solution that combines metagenomics sequencing, a microbiome metabolite panel, and advanced bioinformatics tools to provide enhanced insights into the microbiome.

With over 25 years of experience and more than 15,000 completed client projects, Metabolon has established itself as a leader in metabolomics and related technologies for life sciences research.

The Global Discovery Panel offered by Metabolon is backed by the largest proprietary metabolomics reference library, significantly enhancing its analytical capabilities in both clinical and research environments.